Press Releases
Search by Year
-
02 Apr 2019
University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics
Antwerp (Belgium), London (UK), Marcy l’Etoile (France) – April 1, 2019 - The University of Antwerp, bioMérieux and Wellcome Trust today announced the launch of VALUE-Dx, the first Innovative Medicine...
-
19 Mar 2019
Baxter et bioMérieux annoncent leur collaboration pour améliorer l'identification et le traitement de l’insuffisance rénale aiguë
Baxter International Inc. (NYSE:BAX), a global leader in acute care, and bioMérieux, a world leader in the field of in vitro diagnostics, announced an agreement to develop future biomarkers with the g...
-
27 Feb 2019
bioMérieux – 2018 Financial Results
Organic sales growth of 9.9% for full-year 2018: €2,421 million in sales Up 5.8% as reported Solid fourth-quarter performance, with organic growth of more than 10% Improvement in contributive operatin...
-
07 Feb 2019
bioMérieux acquires Invisible Sentinel, a US-based company specialized in food and beverage molecular testing
bioMérieux, a global player in in vitro diagnostics and world leader in food microbiology testing, today announced the acquisition of Invisible Sentinel Inc. This company, based in Philadelphia (PA) d...
-
19 Dec 2018
bioMérieux receives FDA clearance for BPA and BPN culture bottles used with BACT/ALERT® VIRTUO® for quality control testing of platelets
bioMérieux, a world leader in the field of in vitro diagnostics, announces that its culture bottles BACT/ALERT® BPA and BPN have received 510(k) clearance from the U.S. Food and Drug Administration (F...
-
13 Nov 2018
bioMérieux launches the BIOFIRE® FILMARRAY® Pneumonia Panels with FDA clearance and CE Marking
bioMérieux, a world leader in the field of in vitro diagnostics, today announced the Food and Drug Administration (FDA) 510(k) clearance of the BIOFIRE® FILMARRAY® Pneumonia Panel and the CE-Mark of t...
-
09 Nov 2018
bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market
bioMérieux, a world leader in the field of in vitro diagnostics, today announces the acquisition of a majority holding in Suzhou Hybiome Biomedical Engineering Co.Ltd. This announcement follows the ac...
-
18 Oct 2018
Business review for the nine months ended September 30, 2018
Strong sales dynamic confirmed in third quarter, with an 8.8% increase in organic sales Growth of 9.8% at constant exchange rates and scope of consolidation over the nine months ended September 30: €1...
-
25 Sep 2018
bioMérieux commitments in the CDC’s “AMR Challenge”, a joint public-private sector initiative to accelerate the fight against antimicrobial resistance
Marcy l’Étoile (France) – Sept. 25, 2018 – bioMérieux, a world leader in the field of in vitro diagnostics, is participating in the AMR Challenge, a new Centers for Disease Control and Prevention (CDC...
-
05 Sep 2018
First-Half 2018 Results
Strong sales dynamic, with sales up 10.4% over the first half at constant exchange rates and scope of consolidation: €1,169 million in sales Up 3.1% as reported Contributive operating income before no...